Hila Shaim

3.2k total citations
19 papers, 360 citations indexed

About

Hila Shaim is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Hila Shaim has authored 19 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Hematology and 6 papers in Genetics. Recurrent topics in Hila Shaim's work include Immune Cell Function and Interaction (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Hila Shaim is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Hila Shaim collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Hila Shaim's co-authors include Elizabeth J. Shpall, Katayoun Rezvani, Takuya Sekine, Rayne H. Rouce, Catherine M. Bollard, Brandon Ballard, Muharrem Müftüoğlu, Honghui Liu, Karen R. Rabin and Katy Rezvani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Hila Shaim

18 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hila Shaim United States 10 222 131 80 73 42 19 360
Anni Skovbo Denmark 9 247 1.1× 172 1.3× 119 1.5× 110 1.5× 39 0.9× 13 403
Mathieu Wémeau France 8 101 0.5× 88 0.7× 101 1.3× 83 1.1× 102 2.4× 19 284
Ameera Alsadeq Germany 7 114 0.5× 68 0.5× 63 0.8× 62 0.8× 56 1.3× 16 264
Frederik Stevenaert Belgium 10 337 1.5× 122 0.9× 113 1.4× 119 1.6× 20 0.5× 15 525
Ester Rosenthal Israel 9 110 0.5× 37 0.3× 128 1.6× 97 1.3× 69 1.6× 13 324
Daniela DiFranco Italy 8 285 1.3× 88 0.7× 72 0.9× 173 2.4× 62 1.5× 10 497
Peter J. Schnorr United States 6 177 0.8× 121 0.9× 69 0.9× 122 1.7× 33 0.8× 8 371
Francesca Gianni Italy 6 153 0.7× 87 0.7× 30 0.4× 137 1.9× 89 2.1× 9 335
Lihi Radomir Israel 10 267 1.2× 102 0.8× 26 0.3× 101 1.4× 22 0.5× 12 386
Eric Vroegindeweij Netherlands 6 117 0.5× 55 0.4× 64 0.8× 106 1.5× 21 0.5× 9 287

Countries citing papers authored by Hila Shaim

Since Specialization
Citations

This map shows the geographic impact of Hila Shaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hila Shaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hila Shaim more than expected).

Fields of papers citing papers by Hila Shaim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hila Shaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hila Shaim. The network helps show where Hila Shaim may publish in the future.

Co-authorship network of co-authors of Hila Shaim

This figure shows the co-authorship network connecting the top 25 collaborators of Hila Shaim. A scholar is included among the top collaborators of Hila Shaim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hila Shaim. Hila Shaim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Adkins, Brian D., et al.. (2022). Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study. Journal of Thrombosis and Thrombolysis. 55(1). 74–82. 3 indexed citations
2.
Shaim, Hila, et al.. (2021). A New Viral Coinfection: SARS-CoV-2 Pneumonia and Cytomegalovirus Pneumonitis in a Renal Transplant Recipient. COVID. 1(1). 115–119. 6 indexed citations
3.
Weathers, Shiao‐Pei, Marta Penas‐Prado, Pinaki P. Banerjee, et al.. (2020). A phase I/II clinical trial of autologous CMV-specific T cells in glioblastoma (GBM) patients to reveal a lack of immune effector function.. Journal of Clinical Oncology. 38(15_suppl). 2515–2515. 4 indexed citations
4.
Shaim, Hila, Peter McCaffrey, Judy A. Trieu, Abe DeAnda, & Sean G. Yates. (2020). Evaluating the effects of oseltamivir phosphate on platelet counts: a retrospective review. Platelets. 31(8). 1080–1084. 24 indexed citations
5.
Khoder, Ahmad, Abdullah Alsuliman, Rafet Başar, et al.. (2018). Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Frontiers in Immunology. 8. 1937–1937. 28 indexed citations
6.
Daher, May, Rafet Başar, Hila Shaim, et al.. (2017). The TGF-β/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome. Blood. 130. 53–53. 17 indexed citations
7.
Vitale, Candida, Lorenzo Falchi, Elisa ten Hacken, et al.. (2016). Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics. Clinical Cancer Research. 22(10). 2359–2367. 23 indexed citations
8.
9.
Alsuliman, Abdullah, Muharrem Müftüoğlu, Ahmad Khoder, et al.. (2016). A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood. 129(6). 740–758. 23 indexed citations
10.
Alsuliman, Abdullah, Stanley H. Appel, David R. Beers, et al.. (2016). A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 18(10). 1312–1324. 40 indexed citations
11.
Daher, May, Catherine Sobieski, Hila Shaim, et al.. (2016). KIR Gene Haplotype: An Independent Predictor of Clinical Outcome in MDS Patients. Blood. 128(22). 4330–4330.
12.
Samudio, Ismael, Katayoun Rezvani, Hila Shaim, et al.. (2016). UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells. Blood. 127(21). 2575–2586. 30 indexed citations
13.
Stringaris, Kate, David Marín, A. John Barrett, et al.. (2016). KIR gene haplotype: an independent predictor of clinical outcome in MDS patients. Blood. 128(24). 2819–2823. 21 indexed citations
14.
Rouce, Rayne H., Hila Shaim, Takuya Sekine, et al.. (2015). The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia. 30(4). 800–811. 117 indexed citations
15.
Shaim, Hila, Zeev Estrov, Takuya Sekine, et al.. (2015). The CXCR4/STAT3/IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia (CLL) and Can be Modulated By Lenalidomide. Blood. 126(23). 1709–1709. 3 indexed citations
16.
Kondo, Kayo, Jan A. Burger, M Keating, et al.. (2015). Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions. Blood. 126(23). 1737–1737. 5 indexed citations
17.
18.
Stasi, Antonio Di, Amir Hamdi, Hila Shaim, et al.. (2013). Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(2). S286–S286. 1 indexed citations
19.
Gadoth, Avi, Eitan Auriel, Hila Shaim, & Natan M. Bornstein. (2011). Periprocedural complication rate of carotid endarterectomy versus carotid angioplasty and stenting: a retrospective study and review of the literature.. PubMed. 13(10). 601–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anni Skovbo Breakdown of academic impact, for papers by Mathieu Wémeau Breakdown of academic impact, for papers by Ameera Alsadeq Breakdown of academic impact, for papers by Frederik Stevenaert Breakdown of academic impact, for papers by Ester Rosenthal Breakdown of academic impact, for papers by Daniela DiFranco Breakdown of academic impact, for papers by Peter J. Schnorr Breakdown of academic impact, for papers by Francesca Gianni Breakdown of academic impact, for papers by Lihi Radomir Breakdown of academic impact, for papers by Eric Vroegindeweij
Rankless by CCL
2026